Table 2.

Multilineage reconstitution in the peripheral blood of the transplanted mice

	% in total PBMC
	Myeloid cell	B-cell	T-cell
ALP-BMC-treated Akp2−/− (n = 5) (% donor in each lineages)	11.9 ± 4.2	33.6 ± 20.7	59.0 ± 17.3
	(38.5 ± 7.5)	(21.7 ± 9.9)	(42.0 ± 9.6)
Mock-BMC-treated Akp2+/+ (n = 3) (% donor in each lineages)	9.6 ± 0.9	32.9 ± 8.4	55.7 ± 14.8
	(49.3 ± 19.4)	(29.1 ± 14.3)	(57.1 ± 27.4)

PBMC, peripheral blood mononuclear cells.

Myeloid cells, B-cells, and T-cells were identified by PE-conjugated anti-mouse Mac-1 + Gr-1, B220, and CD3e antibodies, respectively, on day 90 after transplantation. Donor Ly5.1⁺ cells were identified by FITC-conjugated anti-mouse CD45.1 antibody. Data are presented as the mean ± SD. No significant differences were observed.